Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Bone Biologics Corp. (BBLG) had Weighted-Average Shares Outstanding (Diluted) of 1.80M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-0.77M |
|
-- |
|
-- |
|
$0.81M |
|
$-0.81M |
|
$0.03M |
|
$-0.77M |
|
$-0.77M |
|
$-0.77M |
|
$-0.77M |
|
$-0.77M |
|
$-0.77M |
|
$-0.81M |
|
$-0.81M |
|
1.80M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
1.80M |
$-0.43 |
|
$-0.43 |
|
| Balance Sheet Financials | |
$4.44M |
|
-- |
|
-- |
|
$4.44M |
|
$0.51M |
|
-- |
|
-- |
|
$0.51M |
|
$3.92M |
|
$3.92M |
|
$3.92M |
|
1.81M |
|
| Cash Flow Statement Financials | |
$-1.32M |
|
-- |
|
$0.02M |
|
$5.33M |
|
$4.03M |
|
$-1.30M |
|
$0.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.32M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.71% |
|
-19.71% |
|
-17.44% |
|
-19.71% |
|
$2.17 |
|
$-0.74 |
|
$-0.74 |
|